Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Research on cancer vaccines reported by scientists at University Hospital
April 16th, 2008
Current study results from the report, 'Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma,' have been published. According to recent research published in the journal Hormone and Metabolic Research, "The existence of inherited aggressive forms of medullary thyroid carcinoma (MTC) and their resistance to classical therapies make it a prime candidate for adoptive immunotherapy. Highly potent antigen-presenting cells, namely dendritic cells (DCs), may serve as an interesting tool for anticancer vaccination." "Here we report on the IN VITRO findings of a vaccination trial in five MTC patients, who were...
Source: Vaccine Weekly (2008-04-16)
|
